Abstract Purpose of the Review Esophageal cancer is the sixth most common cause of
cancer death globally. Squamous cell carcinoma of the esophagus (ESCC) is the …

Oesophageal cancer is the sixth most common cause of cancer-related death worldwide
and is therefore a major global health challenge. The two major subtypes of oesophageal …

Oesophageal cancer is the seventh most common cancer worldwide, with 604 000 new
cases diagnosed in 2020. It is the sixth most common cause of cancer-related mortality, with …

Oesophageal cancer is the 19th most common cancer in the European Union (EU), with∼
45 900 new cases diagnosed in 2012 (1% of the total). In the EU, the highest age …

PURPOSE Gastric cancer (GC) with peritoneal metastases (PMs) is a poor prognostic
evolution. Cytoreductive surgery (CRS) yields promising results, but the impact of …

Oesophageal cancer is a clinically challenging disease that requires a multidisciplinary
approach. Extensive treatment might be associated with a considerable decline in health …

Background Neoadjuvant chemoradiotherapy (nCRT) plus surgery is a standard treatment
for locally advanced oesophageal cancer. With this treatment, 29% of patients have a …

Importance Ninety-day mortality rates after esophagectomy are an indicator of the quality of
surgical oncologic management. Accurate risk prediction based on large data sets may aid …

The primary objective of these guidelines was to provide general clinicians with information
that would guide them to make informed choices from the available diagnosis/treatment …

Introduction Up to 32% of patients with esophageal cancer show a pathological complete
response (ypCR) after neoadjuvant therapy. To prevent overtreatment, the indication to …